Ignite Creation Date:
2024-05-06 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05266937
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-01
First Post:
2020-02-10
Brief Title:
Atezolizumab Plus CArboplatin Plus Nab-paclitaxel
Sponsor:
Organization:
Consorzio Oncotech